See more : Winnergy Medical Public Company Limited (WINMED.BK) Income Statement Analysis – Financial Results
Complete financial analysis of MatsukiyoCocokara & Co. (MSMKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MatsukiyoCocokara & Co., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Harworth Group plc (HWG.L) Income Statement Analysis – Financial Results
- Elgi Rubber Company Limited (ELGIRUBCO.NS) Income Statement Analysis – Financial Results
- Tantalex Lithium Resources Corp. (TTX.CN) Income Statement Analysis – Financial Results
- Geo Limited (GEO.NZ) Income Statement Analysis – Financial Results
- SUUMAYA CORPORATION LIMITED (SUUMAYA.BO) Income Statement Analysis – Financial Results
MatsukiyoCocokara & Co. (MSMKF)
About MatsukiyoCocokara & Co.
MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies in Japan. As of June 30, 2020, it operated through a network of 1,726 stores in 47 prefectures in Japan. MatsukiyoCocokara & Co. was founded in 1932 and is based in Matsudo, Japan.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,022.53B | 951.25B | 729.97B | 556.91B | 590.59B | 575.99B | 558.88B | 535.13B | 536.05B | 485.51B | 495.39B | 456.31B | 434.60B | 428.18B | 393.01B | 392.27B | 390.93B | 345.46B | 312.98B | 305.31B |
Cost of Revenue | 690.73B | 621.93B | 489.67B | 374.81B | 401.15B | 396.51B | 389.67B | 376.85B | 380.38B | 345.35B | 352.73B | 326.11B | 312.11B | 308.95B | 285.29B | 285.54B | 285.36B | 252.63B | 229.48B | 225.42B |
Gross Profit | 331.80B | 329.32B | 240.30B | 182.10B | 189.44B | 179.48B | 169.21B | 158.29B | 155.67B | 140.17B | 142.65B | 130.20B | 122.49B | 119.23B | 107.72B | 106.73B | 105.58B | 92.83B | 83.50B | 79.89B |
Gross Profit Ratio | 32.45% | 34.62% | 32.92% | 32.70% | 32.08% | 31.16% | 30.28% | 29.58% | 29.04% | 28.87% | 28.80% | 28.53% | 28.18% | 27.85% | 27.41% | 27.21% | 27.01% | 26.87% | 26.68% | 26.17% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 253.89B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.74B | 2.94B | 2.68B | 2.56B | 2.54B | 2.15B | 2.00B | 1.99B |
Selling & Marketing | 2.25B | 2.13B | 1.69B | 1.40B | 1.79B | 1.39B | 1.73B | 1.82B | 2.01B | 2.00B | 2.13B | 1.99B | 2.11B | 2.48B | 2.73B | 3.40B | 4.15B | 6.51B | 6.25B | 5.66B |
SG&A | 256.14B | 2.13B | 1.69B | 1.40B | 1.79B | 1.39B | 1.73B | 1.82B | 2.01B | 2.00B | 2.13B | 1.99B | 4.85B | 5.42B | 5.41B | 5.96B | 6.69B | 8.66B | 8.25B | 7.65B |
Other Expenses | 22.25B | 3.93B | 3.32B | 2.12B | 1.99B | 2.52B | 2.13B | 1.97B | 1.95B | 1.93B | 1.65B | 1.64B | 1.44B | 2.06B | 2.04B | 1.81B | 1.39B | 793.00M | 1.47B | 1.34B |
Operating Expenses | 278.39B | 267.04B | 198.88B | 150.56B | 151.87B | 143.45B | 135.64B | 129.85B | 128.25B | 122.53B | 120.21B | 110.51B | 72.64B | 70.68B | 64.10B | 62.63B | 60.26B | 54.92B | 49.64B | 47.33B |
Cost & Expenses | 946.83B | 888.97B | 688.56B | 525.37B | 553.03B | 539.96B | 525.31B | 506.70B | 508.63B | 467.87B | 472.94B | 436.62B | 384.75B | 379.64B | 349.39B | 348.17B | 345.62B | 307.56B | 279.12B | 272.75B |
Interest Income | 136.00M | 130.00M | 107.00M | 88.00M | 103.00M | 116.00M | 132.00M | 146.00M | 173.00M | 193.00M | 191.00M | 190.00M | 206.00M | 219.00M | 375.00M | 236.00M | 274.00M | 248.00M | 204.00M | 172.00M |
Interest Expense | 57.00M | 53.00M | 60.00M | 44.00M | 18.00M | 17.00M | 16.00M | 19.00M | 23.00M | 41.00M | 34.00M | 63.00M | 77.00M | 179.00M | 246.00M | 358.00M | 338.00M | 186.00M | 80.00M | 97.00M |
Depreciation & Amortization | 22.37B | 20.84B | 14.86B | 8.58B | 8.40B | 8.23B | 7.70B | 7.95B | 7.57B | 7.16B | 6.42B | 6.02B | 5.45B | 5.04B | 3.62B | 3.59B | 3.34B | 2.57B | 2.14B | 2.39B |
EBITDA | 98.02B | 83.12B | 56.27B | 40.10B | 45.96B | 44.26B | 41.27B | 36.38B | 34.99B | 24.79B | 28.86B | 25.51B | 23.77B | 19.62B | 18.45B | 18.72B | 17.58B | 16.20B | 6.79B | 12.43B |
EBITDA Ratio | 9.59% | 9.21% | 8.19% | 7.67% | 8.20% | 8.20% | 7.84% | 7.25% | 7.11% | 5.61% | 6.25% | 6.09% | 13.09% | 13.02% | 12.68% | 12.79% | 12.92% | 12.01% | 12.02% | 11.94% |
Operating Income | 75.71B | 62.28B | 41.41B | 31.53B | 37.56B | 36.03B | 33.57B | 28.43B | 27.42B | 17.63B | 22.44B | 19.69B | 49.85B | 48.55B | 43.62B | 44.10B | 45.32B | 37.90B | 33.86B | 32.57B |
Operating Income Ratio | 7.40% | 6.55% | 5.67% | 5.66% | 6.36% | 6.25% | 6.01% | 5.31% | 5.11% | 3.63% | 4.53% | 4.31% | 11.47% | 11.34% | 11.10% | 11.24% | 11.59% | 10.97% | 10.82% | 10.67% |
Total Other Income/Expenses | 5.54B | 2.63B | 8.54B | 1.04B | 1.52B | 1.34B | 853.00M | 384.00M | -403.00M | 2.02B | 268.00M | -263.00M | 135.00M | -34.14B | -29.46B | -29.91B | -32.15B | -24.46B | -29.17B | -22.62B |
Income Before Tax | 81.25B | 64.91B | 49.63B | 32.62B | 39.08B | 37.37B | 34.42B | 28.82B | 27.02B | 19.65B | 22.71B | 19.42B | 18.24B | 14.40B | 14.15B | 14.19B | 13.17B | 13.45B | 4.69B | 9.95B |
Income Before Tax Ratio | 7.95% | 6.82% | 6.80% | 5.86% | 6.62% | 6.49% | 6.16% | 5.38% | 5.04% | 4.05% | 4.58% | 4.26% | 4.20% | 3.36% | 3.60% | 3.62% | 3.37% | 3.89% | 1.50% | 3.26% |
Income Tax Expense | 28.63B | 24.14B | 15.02B | 11.05B | 12.90B | 12.33B | 11.66B | 8.70B | 9.14B | 7.94B | 9.27B | 8.00B | 8.06B | 6.92B | 6.68B | 6.25B | 6.23B | 9.21B | 2.34B | 4.40B |
Net Income | 52.35B | 40.55B | 34.38B | 21.60B | 26.18B | 25.04B | 22.76B | 20.12B | 17.85B | 11.62B | 13.36B | 11.27B | 9.96B | 7.29B | 7.28B | 7.73B | 6.80B | 4.13B | 2.31B | 5.51B |
Net Income Ratio | 5.12% | 4.26% | 4.71% | 3.88% | 4.43% | 4.35% | 4.07% | 3.76% | 3.33% | 2.39% | 2.70% | 2.47% | 2.29% | 1.70% | 1.85% | 1.97% | 1.74% | 1.20% | 0.74% | 1.81% |
EPS | 125.31 | 96.02 | 93.81 | 70.15 | 85.01 | 60.02 | 214.92 | 189.08 | 166.44 | 107.82 | 123.38 | 118.86 | 106.43 | 75.74 | 76.35 | 80.75 | 67.13 | 38.78 | 21.16 | 52.32 |
EPS Diluted | 125.27 | 95.99 | 93.78 | 70.12 | 84.98 | 60.02 | 214.92 | 188.97 | 166.35 | 107.77 | 122.31 | 102.26 | 90.71 | 68.82 | 76.35 | 80.75 | 67.13 | 38.78 | 21.16 | 52.32 |
Weighted Avg Shares Out | 417.74M | 422.26M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M |
Weighted Avg Shares Out (Dil) | 417.86M | 422.38M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M | 417.14M |
Source: https://incomestatements.info
Category: Stock Reports